ATHA
Price
$7.21
Change
-$0.30 (-3.99%)
Updated
Dec 24 closing price
Capitalization
28.44M
Intraday BUY SELL Signals
LPCN
Price
$4.65
Change
+$0.04 (+0.87%)
Updated
Dec 24 closing price
Capitalization
25.82M
Intraday BUY SELL Signals
Interact to see
Advertisement

ATHA vs LPCN

Header iconATHA vs LPCN Comparison
Open Charts ATHA vs LPCNBanner chart's image
Athira Pharma
Price$7.21
Change-$0.30 (-3.99%)
Volume$74.63K
Capitalization28.44M
Lipocine
Price$4.65
Change+$0.04 (+0.87%)
Volume$26.62K
Capitalization25.82M
ATHA vs LPCN Comparison Chart in %
ATHA
Daily Signal:
Gain/Loss:
LPCN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATHA vs. LPCN commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Buy and LPCN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ATHA: $7.21 vs. LPCN: $4.65)
Brand notoriety: ATHA and LPCN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 5% vs. LPCN: 46%
Market capitalization -- ATHA: $28.44M vs. LPCN: $25.82M
ATHA [@Biotechnology] is valued at $28.44M. LPCN’s [@Biotechnology] market capitalization is $25.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileLPCN’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • LPCN’s FA Score: 0 green, 5 red.
According to our system of comparison, ATHA is a better buy in the long-term than LPCN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 6 TA indicator(s) are bullish while LPCN’s TA Score has 5 bullish TA indicator(s).

  • ATHA’s TA Score: 6 bullish, 4 bearish.
  • LPCN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than LPCN.

Price Growth

ATHA (@Biotechnology) experienced а +74.37% price change this week, while LPCN (@Biotechnology) price change was +26.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHA($28.4M) has a higher market cap than LPCN($25.8M). ATHA YTD gains are higher at: 22.891 vs. LPCN (-4.713). LPCN has higher annual earnings (EBITDA): -6.25M vs. ATHA (-38.3M). ATHA has more cash in the bank: 25.2M vs. LPCN (15.1M). ATHA has less debt than LPCN: ATHA (912K) vs LPCN (1.48M). LPCN has higher revenues than ATHA: LPCN (4.32M) vs ATHA (0).
ATHALPCNATHA / LPCN
Capitalization28.4M25.8M110%
EBITDA-38.3M-6.25M613%
Gain YTD22.891-4.713-486%
P/E RatioN/AN/A-
Revenue04.32M-
Total Cash25.2M15.1M167%
Total Debt912K1.48M62%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHALPCN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signal:
Gain/Loss:
LPCN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHAR18.090.85
+4.93%
Pharming Group NV
APO148.850.48
+0.32%
Apollo Global Management
BIPC46.500.05
+0.11%
Brookfield Infrastructure Corp
BOLD1.21N/A
N/A
Boundless Bio
GPRO1.57-0.01
-0.63%
GoPro

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with ALNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
-3.99%
ALNY - ATHA
35%
Loosely correlated
+0.50%
OGEN - ATHA
35%
Loosely correlated
+0.68%
NAGE - ATHA
34%
Loosely correlated
+1.54%
IPSC - ATHA
33%
Poorly correlated
+6.19%
CDXS - ATHA
32%
Poorly correlated
+1.82%
More

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
+0.87%
SPRY - LPCN
63%
Loosely correlated
+4.08%
HYFT - LPCN
43%
Loosely correlated
+1.18%
ZNTL - LPCN
36%
Loosely correlated
+2.22%
IPSC - LPCN
34%
Loosely correlated
+6.19%
ATHA - LPCN
30%
Poorly correlated
-3.99%
More